Inotiv (NOTV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Dec, 2025Executive summary
Q4 2025 revenue rose 5.9% year-over-year to $138.1M; full year revenue up 4.5% to $513M, driven by DSA segment growth.
Q4 net loss attributable to shareholders was $8.6M ($0.25/share), improved from $18.9M ($0.73/share) in Q4 2024.
Q4 Adjusted EBITDA was $11.8M (8.5% margin), up from $5.4M (4.1%) in Q4 2024.
Q4 operating loss decreased to $6.8M, and full year operating loss down to $30.9M.
Overcame a significant cybersecurity incident in Q4, with minimal disruption to client delivery and continued business momentum.
Financial highlights
FY 2025 net loss was $68.6M (13.4% of revenue), improved from $108.9M (22.2%) in FY 2024.
Full year Adjusted EBITDA: $34M (6.6% margin), up from $18.2M (3.7%) in 2024.
Cash and cash equivalents at year-end were $21.7M; net debt at $402.1M as of September 30, 2025.
Capital expenditures for FY 2025 totaled $16.6M (3.2% of revenue), down from $22.3M in FY 2024.
Q4 interest expense: $15.7M, up from $12.3M in Q4 2024.
Outlook and guidance
Not providing formal fiscal 2026 guidance due to market and tariff uncertainties; will resume guidance when visibility improves.
Early Q1 2026 trends show continued strength in DSA quoting and awards, with optimism for ongoing revenue growth.
Management remains focused on improving cash flow, margins, and client metrics, with continued execution of strategic plans.
Latest events from Inotiv
- Q1 2026 revenue hit $120.9M as efficiency, site optimization, and compliance drive growth.NOTV
Investor presentation9 Feb 2026 - Revenue up 0.8% with DSA growth, but net loss and liquidity risks persist.NOTV
Q1 20269 Feb 2026 - Q3 revenue fell 32.8% with a $26.1M loss; legal issues resolved but liquidity risks remain.NOTV
Q3 20242 Feb 2026 - New services and capacity drive DSA growth, while NHP and small animal markets adjust to shifting demand.NOTV
Jefferies Global Healthcare Conference1 Feb 2026 - FY 2024 revenue fell 14.3% with margin pressure, but operational changes target recovery in 2025.NOTV
Q4 202412 Jan 2026 - Operational optimization and DSA growth drive revenue and margin expansion.NOTV
H.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025 - Registering $350M in securities, including $50M at-the-market shares, amid going concern risk.NOTV
Registration Filing16 Dec 2025 - Resale registration covers 4.1M shares from warrants; up to $6.5M may be raised if exercised for cash.NOTV
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor, executive pay, and equity plan amid governance focus.NOTV
Proxy Filing1 Dec 2025